Swedbank AB Reduces Position in The Cooper Companies, Inc. (NASDAQ:COO)

Swedbank AB cut its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 10.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,429,602 shares of the medical device company's stock after selling 170,818 shares during the period. Swedbank AB owned about 0.72% of Cooper Companies worth $157,742,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Benjamin F. Edwards & Company Inc. boosted its position in Cooper Companies by 248.6% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company's stock valued at $25,000 after buying an additional 174 shares in the last quarter. Innealta Capital LLC bought a new position in shares of Cooper Companies during the second quarter valued at $25,000. Covestor Ltd increased its holdings in Cooper Companies by 305.9% in the first quarter. Covestor Ltd now owns 276 shares of the medical device company's stock valued at $28,000 after purchasing an additional 208 shares during the period. Crewe Advisors LLC increased its stake in shares of Cooper Companies by 286.4% in the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company's stock valued at $30,000 after buying an additional 252 shares during the period. Finally, Tortoise Investment Management LLC boosted its holdings in Cooper Companies by 75.4% in the second quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company's stock valued at $34,000 after acquiring an additional 169 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Analyst Upgrades and Downgrades

COO has been the subject of several recent analyst reports. Stifel Nicolaus reiterated a "buy" rating and set a $115.00 price objective (up from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a research report on Thursday, August 29th. Piper Sandler upped their target price on Cooper Companies from $115.00 to $120.00 and gave the company an "overweight" rating in a research report on Thursday, August 29th. Robert W. Baird lifted their target price on Cooper Companies from $118.00 to $125.00 and gave the stock an "outperform" rating in a report on Thursday, August 29th. Finally, Wells Fargo & Company increased their price target on Cooper Companies from $110.00 to $115.00 and gave the stock an "overweight" rating in a report on Thursday, August 29th. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $115.00.

Cooper Companies Stock Up 0.8 %

Shares of NASDAQ:COO traded up $0.87 during midday trading on Tuesday, hitting $108.55. 829,395 shares of the company's stock were exchanged, compared to its average volume of 1,109,214. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18. The Cooper Companies, Inc. has a 12 month low of $75.93 and a 12 month high of $112.38. The company has a market cap of $21.61 billion, a PE ratio of 63.85, a price-to-earnings-growth ratio of 2.56 and a beta of 0.98. The stock has a 50 day moving average price of $103.37 and a 200-day moving average price of $96.22.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping analysts' consensus estimates of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. During the same period in the previous year, the company posted $0.84 EPS. The company's revenue for the quarter was up 7.8% on a year-over-year basis. On average, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.65 EPS for the current fiscal year.

Insider Buying and Selling at Cooper Companies

In related news, CAO Agostino Ricupati sold 1,601 shares of the business's stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the transaction, the chief accounting officer now directly owns 4,818 shares in the company, valued at approximately $520,488.54. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, CAO Agostino Ricupati sold 1,601 shares of Cooper Companies stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares in the company, valued at approximately $520,488.54. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Albert G. White III sold 114,992 shares of the company's stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the transaction, the chief executive officer now owns 165,273 shares of the company's stock, valued at $18,267,624.69. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 256,373 shares of company stock worth $27,637,427. Corporate insiders own 2.00% of the company's stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.